Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eveliina Arponen

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2009
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancerJan Seppälä, Marko Seppänen, Eveliina Arponen, et al.
Neuroimage|August 6, 2018
Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET studyJoonas Majuri, Juho Joutsa, Eveliina Arponen, et al.
Journal of Behavioral Addictions|August 10, 2023
Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory studyAlbert Bellmunt-Gil, Joonas Majuri, Eveliina Arponen, et al.
EJNMMI Radiopharmacy and Chemistry|March 25, 2024
In-target production of [<sup>11</sup>C]CH<sub>4</sub> from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperatureSemi Helin, Johan Rajander, Jussi Aromaa, et al.
Synapse (New York, N.Y.)|November 13, 2015
Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070Jussi Lehto, Annalotta Scheinin, Jarkko Johansson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 20, 2017
Opioid Release after High-Intensity Interval Training in Healthy Human SubjectsTiina Saanijoki, Lauri Tuominen, Jetro J Tuulari, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 17, 2017
Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [<sup>11</sup>C]MADAMJoonas Majuri, Juho Joutsa, Jarkko Johansson, et al.
Psychological Medicine|February 11, 2021
The neural substrates of risky rewards and losses in healthy volunteers and patient groups: a PET imaging studyNikolina Skandali, Joonas Majuri, Juho Joutsa, et al.
Psychopharmacology|April 29, 2015
Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjectsJussi Lehto, Jarkko Johansson, Lauri Vuorilehto, et al.
Human Brain Mapping|June 10, 2018
Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor systemTiina Saanijoki, Lauri Nummenmaa, Jetro J Tuulari, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2009
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancerJan Seppälä, Marko Seppänen, Eveliina Arponen, et al.
Neuroimage|August 6, 2018
Dopamine synthesis capacity correlates with µ-opioid receptor availability in the human basal ganglia: A triple-tracer PET studyJoonas Majuri, Juho Joutsa, Eveliina Arponen, et al.
Journal of Behavioral Addictions|August 10, 2023
Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory studyAlbert Bellmunt-Gil, Joonas Majuri, Eveliina Arponen, et al.
EJNMMI Radiopharmacy and Chemistry|March 25, 2024
In-target production of [<sup>11</sup>C]CH<sub>4</sub> from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperatureSemi Helin, Johan Rajander, Jussi Aromaa, et al.
Synapse (New York, N.Y.)|November 13, 2015
Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070Jussi Lehto, Annalotta Scheinin, Jarkko Johansson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 20, 2017
Opioid Release after High-Intensity Interval Training in Healthy Human SubjectsTiina Saanijoki, Lauri Tuominen, Jetro J Tuulari, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 17, 2017
Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [<sup>11</sup>C]MADAMJoonas Majuri, Juho Joutsa, Jarkko Johansson, et al.
Psychological Medicine|February 11, 2021
The neural substrates of risky rewards and losses in healthy volunteers and patient groups: a PET imaging studyNikolina Skandali, Joonas Majuri, Juho Joutsa, et al.
Psychopharmacology|April 29, 2015
Sensitivity of [(11)C]ORM-13070 to increased extracellular noradrenaline in the CNS - a PET study in human subjectsJussi Lehto, Jarkko Johansson, Lauri Vuorilehto, et al.
Human Brain Mapping|June 10, 2018
Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor systemTiina Saanijoki, Lauri Nummenmaa, Jetro J Tuulari, et al.
Pageof 3